| scholarly article | Q13442814 |
| P50 | author | Annie Turkieh | Q58816440 |
| Florence Pinet | Q32427967 | ||
| P2093 | author name string | Philippe Amouyel | |
| Jean-Luc Balligand | |||
| Maggy Chwastyniak | |||
| Olivia Beseme | |||
| Nicolas Lamblin | |||
| Christophe Bauters | |||
| Sina Porouchani | |||
| P2860 | cites work | Up-regulation of the clusterin gene after proteotoxic stress: implication of HSF1-HSF2 heterocomplexes. | Q40342417 |
| Synthesis and functional analyses of nuclear clusterin, a cell death protein | Q40674770 | ||
| Stress-induced transcription of the clusterin/apoJ gene. | Q42200027 | ||
| Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction | Q43190981 | ||
| Clusterin facilitates in vivo clearance of extracellular misfolded proteins | Q43583442 | ||
| Clusterin: a protective mediator for ischemic cardiomyocytes? | Q46581040 | ||
| Clusterin protects neurons against intracellular proteotoxicity | Q47101840 | ||
| Involvement of clusterin and the aggresome in abnormal protein deposits in myofibrillar myopathies and inclusion body myositis. | Q53269828 | ||
| Exosomal clusterin, identified in the pericardial fluid, improves myocardial performance following MI through epicardial activation, enhanced arteriogenesis and reduced apoptosis. | Q53433900 | ||
| Rapamycin protects cardiomyocytes against anoxia/reoxygenation injury by inducing autophagy through the PI3k/Akt pathway. | Q53611960 | ||
| Expression and Implication of Clusterin in Left Ventricular Remodeling After Myocardial Infarction. | Q54976497 | ||
| Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy | Q61443158 | ||
| Trehalose-Induced Activation of Autophagy Improves Cardiac Remodeling After Myocardial Infarction. | Q64885580 | ||
| Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells | Q71087317 | ||
| Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction | Q72660259 | ||
| Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction | Q78624858 | ||
| The role of autophagy emerging in postinfarction cardiac remodelling | Q83619910 | ||
| The ubiquitin proteasome system and myocardial ischemia | Q28280898 | ||
| HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS | Q28306195 | ||
| Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death | Q28579471 | ||
| Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide | Q29977749 | ||
| Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survival | Q30611108 | ||
| Proteasomal and lysosomal protein degradation and heart disease | Q33573707 | ||
| Autophagic-lysosomal inhibition compromises ubiquitin-proteasome system performance in a p62 dependent manner in cardiomyocytes | Q33800568 | ||
| The ubiquitin proteasome system in human cardiomyopathies and heart failure | Q33816688 | ||
| Clusterin protects H9c2 cardiomyocytes from oxidative stress-induced apoptosis via Akt/GSK-3β signaling pathway | Q34587120 | ||
| The interplay between autophagy and the ubiquitin-proteasome system in cardiac proteotoxicity | Q34778984 | ||
| Clusterin is a short half-life, poly-ubiquitinated protein, which controls the fate of prostate cancer cells. | Q34919877 | ||
| Transcriptional and posttranslational regulation of clusterin by the two main cellular proteolytic pathways | Q34974750 | ||
| Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice | Q35187068 | ||
| Proapoptotic role of nuclear clusterin in brain | Q35374719 | ||
| Proteasome malfunction activates macroautophagy in the heart | Q35536300 | ||
| Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia-reperfusion injury in mice | Q36184878 | ||
| Autophagy is impaired in cardiac ischemia-reperfusion injury | Q36235484 | ||
| Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation | Q36579884 | ||
| Protein quality control and degradation in cardiomyocytes | Q36952213 | ||
| Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy | Q37012635 | ||
| Proteasome inhibition during myocardial infarction | Q37595119 | ||
| Role of ubiquitin-proteasome system (UPS) in left ventricular hypertrophy (LVH). | Q38189389 | ||
| The CLU-files: disentanglement of a mystery | Q38670777 | ||
| Autophagy during cardiac remodeling | Q38672214 | ||
| Requirement of clusterin expression for prosurvival autophagy in hypoxic kidney tubular epithelial cells | Q38819963 | ||
| A novel crosstalk between two major protein degradation systems: regulation of proteasomal activity by autophagy. | Q39112279 | ||
| Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis | Q39271816 | ||
| Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells | Q39780649 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 608 | |
| P577 | publication date | 2019-08-13 | |
| P1433 | published in | Cell Death and Disease | Q2197222 |
| P1476 | title | Increased clusterin levels after myocardial infarction is due to a defect in protein degradation systems activity | |
| P478 | volume | 10 |
Search more.